News Releases

June 15, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas

Continued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunology ROCHESTER, Mich. , June 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies,

PDF Version
June 1, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies

ROCHESTER, Mich. , June 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s CEO, will participate in the LD Micro Virtual

PDF Version
May 25, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference

ROCHESTER, Mich. , May 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s, CEO will participate in a fireside chat at the

PDF Version
May 11, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021

ROCHESTER, Mich. , May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will participate in RBC Capital Markets Global Healthcare Virtual Conference .

PDF Version
May 6, 2021 at 4:01 PM EDT

Summary Toggle OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health

Revenue Up 48% to $11.2 million , closing on 33 enterprise contracts Expanded recurring revenue stream, reaching new base of customers Cash flow positive from operations of $1.7 million ROCHESTER, Mich. , May 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading

PDF Version
April 28, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4:30 p.m. ET

ROCHESTER, Mich. , April 28, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, May 6, 2021 , at 4:30 p.m.

PDF Version
April 27, 2021 at 7:51 AM EDT

Summary Toggle OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care

Several New Partnerships Expand Reach to Over 50% of Oncologists in the U.S. and Unlock Novel Touchpoints for Life Sciences to Engage Physicians ROCHESTER, Mich. , April 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science

PDF Version
April 13, 2021 at 7:51 AM EDT

Summary Toggle OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year

Ranked #277, highlighting the growth potential and convergence between technology and healthcare ROCHESTER, Mich. , April 13, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received

PDF Version
March 16, 2021 at 7:30 AM EDT

Summary Toggle OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021

ROCHESTER, Mich. , March 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has secured 19 new enterprise-level deals for 2021 that provide access to the company’s full suite of solutions

PDF Version
March 3, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

ROCHESTER, Mich. , March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the 33 rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021

PDF Version